1	Enhanced	enhance	VBN	VBN	_	2	amod	_	_
2	virulence	virulence	NN	NN	_	0	ROOT	_	_
3	of	of	IN	IN	_	2	prep	_	_
4	Chlamydia	chlamydia	NN	NN	_	7	nn	_	_
5	muridarum	muridarum	NN	NN	_	7	nn	_	_
6	respiratory	respiratory	JJ	JJ	_	7	amod	_	_
7	infections	infection	NNS	NNS	_	3	pobj	_	_
8	in	in	IN	IN	_	2	prep	_	_
9	the	the	DT	DT	_	10	det	_	_
10	absence	absence	NN	NN	_	8	pobj	_	_
11	of	of	IN	IN	_	10	prep	_	_
12	TLR2	tlr2	NN	NN	_	13	nn	_	_
13	activation	activation	NN	NN	_	11	pobj	_	_
14	.	.	.	.	_	2	punct	_	_

1	Chlamydia	chlamydia	NN	NN	_	2	nn	_	_
2	trachomatis	trachomatis	NN	NN	_	8	nsubj	_	_
3	is	be	VBZ	VBZ	_	8	cop	_	_
4	a	a	DT	DT	_	8	det	_	_
5	common	common	JJ	JJ	_	8	amod	_	_
6	sexually	sexually	RB	RB	_	7	advmod	_	_
7	transmitted	transmit	VBN	VBN	_	8	amod	_	_
8	pathogen	pathogen	NN	NN	_	0	ROOT	_	_
9	and	and	CC	CC	_	8	cc	_	_
10	is	be	VBZ	VBZ	_	11	auxpass	_	_
11	associated	associate	VBN	VBN	_	8	conj	_	_
12	with	with	IN	IN	_	11	prep	_	_
13	infant	infant	NN	NN	_	14	nn	_	_
14	pneumonia	pneumonia	NN	NN	_	12	pobj	_	_
15	.	.	.	.	_	8	punct	_	_

1	Data	datum	NNS	NNS	_	12	nsubj	_	_
2	from	from	IN	IN	_	1	prep	_	_
3	the	the	DT	DT	_	6	det	_	_
4	female	female	JJ	JJ	_	6	amod	_	_
5	mouse	mouse	NN	NN	_	6	nn	_	_
6	model	model	NN	NN	_	2	pobj	_	_
7	of	of	IN	IN	_	6	prep	_	_
8	genital	genital	JJ	JJ	_	11	amod	_	_
9	tract	tract	NN	NN	_	11	nn	_	_
10	chlamydia	chlamydia	NN	NN	_	11	nn	_	_
11	infection	infection	NN	NN	_	7	pobj	_	_
12	suggests	suggest	VBZ	VBZ	_	0	ROOT	_	_
13	a	a	DT	DT	_	14	det	_	_
14	requirement	requirement	NN	NN	_	12	dobj	_	_
15	for	for	IN	IN	_	14	prep	_	_
16	TLR2-dependent	tlr2-dependent	JJ	JJ	_	17	amod	_	_
17	signaling	signaling	NN	NN	_	15	pobj	_	_
18	in	in	IN	IN	_	17	prep	_	_
19	the	the	DT	DT	_	20	det	_	_
20	induction	induction	NN	NN	_	18	pobj	_	_
21	of	of	IN	IN	_	20	prep	_	_
22	inflammation	inflammation	NN	NN	_	21	pobj	_	_
23	and	and	CC	CC	_	22	cc	_	_
24	oviduct	oviduct	NN	NN	_	25	nn	_	_
25	pathology	pathology	NN	NN	_	22	conj	_	_
26	.	.	.	.	_	12	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	hypothesized	hypothesize	VBD	VBD	_	0	ROOT	_	_
3	that	that	IN	IN	_	14	mark	_	_
4	the	the	DT	DT	_	5	det	_	_
5	role	role	NN	NN	_	14	nsubj	_	_
6	of	of	IN	IN	_	5	prep	_	_
7	TLR2	tlr2	NN	NN	_	6	pobj	_	_
8	in	in	IN	IN	_	5	prep	_	_
9	moderating	moderate	VBG	VBG	_	8	pcomp	_	_
10	mucosal	mucosal	JJ	JJ	_	11	amod	_	_
11	inflammation	inflammation	NN	NN	_	9	dobj	_	_
12	is	be	VBZ	VBZ	_	14	cop	_	_
13	site	site	NN	NN	_	14	npadvmod	_	_
14	specific	specific	JJ	JJ	_	2	ccomp	_	_
15	.	.	.	.	_	2	punct	_	_

1	In	in	IN	IN	_	4	mark	_	_
2	order	order	NN	NN	_	4	dep	_	_
3	to	to	TO	TO	_	4	aux	_	_
4	investigate	investigate	VB	VB	_	0	ROOT	_	_
5	this	this	DT	DT	_	4	dobj	_	_
6	,	,	,	,	_	9	punct	_	_
7	we	we	PRP	PRP	_	9	dep	_	_
8	infected	infected	JJ	JJ	_	9	amod	_	_
9	mice	mouse	NNS	NNS	_	4	dep	_	_
10	via	via	IN	IN	_	9	prep	_	_
11	the	the	DT	DT	_	13	det	_	_
12	intranasal	intranasal	JJ	JJ	_	13	amod	_	_
13	route	route	NN	NN	_	10	pobj	_	_
14	with	with	IN	IN	_	13	prep	_	_
15	C.	C.	NNP	NNP	_	16	nn	_	_
16	muridarum	muridarum	NN	NN	_	14	pobj	_	_
17	and	and	CC	CC	_	9	cc	_	_
18	observed	observe	VBN	VBN	_	9	conj	_	_
19	that	that	IN	IN	_	28	mark	_	_
20	in	in	IN	IN	_	28	prep	_	_
21	the	the	DT	DT	_	22	det	_	_
22	absence	absence	NN	NN	_	20	pobj	_	_
23	of	of	IN	IN	_	22	prep	_	_
24	TLR2	tlr2	NN	NN	_	25	nn	_	_
25	activation	activation	NN	NN	_	23	pobj	_	_
26	,	,	,	,	_	28	punct	_	_
27	mice	mouse	NNS	NNS	_	28	nsubj	_	_
28	had	have	VBD	VBD	_	18	ccomp	_	_
29	more	more	RBR	RBR	_	30	advmod	_	_
30	severe	severe	JJ	JJ	_	31	amod	_	_
31	disease	disease	NN	NN	_	28	dobj	_	_
32	,	,	,	,	_	31	punct	_	_
33	higher	higher	JJR	JJR	_	36	amod	_	_
34	lung	lung	NN	NN	_	36	nn	_	_
35	cytokine	cytokine	NN	NN	_	36	nn	_	_
36	levels	level	NNS	NNS	_	31	conj	_	_
37	,	,	,	,	_	31	punct	_	_
38	and	and	CC	CC	_	31	cc	_	_
39	an	a	DT	DT	_	41	det	_	_
40	exaggerated	exaggerated	JJ	JJ	_	41	amod	_	_
41	influx	influx	NN	NN	_	31	conj	_	_
42	of	of	IN	IN	_	41	prep	_	_
43	neutrophils	neutrophil	NNS	NNS	_	42	pobj	_	_
44	and	and	CC	CC	_	43	cc	_	_
45	T-cells	t-cell	NNS	NNS	_	43	conj	_	_
46	into	into	IN	IN	_	41	prep	_	_
47	the	the	DT	DT	_	48	det	_	_
48	lungs	lung	NNS	NNS	_	46	pobj	_	_
49	.	.	.	.	_	9	punct	_	_

1	This	this	DT	DT	_	5	nsubjpass	_	_
2	could	could	MD	MD	_	5	aux	_	_
3	not	not	RB	RB	_	5	neg	_	_
4	be	be	VB	VB	_	5	auxpass	_	_
5	explained	explain	VBN	VBN	_	0	ROOT	_	_
6	by	by	IN	IN	_	5	prep	_	_
7	impaired	impaired	JJ	JJ	_	9	amod	_	_
8	bacterial	bacterial	JJ	JJ	_	9	amod	_	_
9	clearance	clearance	NN	NN	_	6	pobj	_	_
10	as	as	IN	IN	_	13	mark	_	_
11	TLR2-deficient	tlr2-deficient	JJ	JJ	_	12	amod	_	_
12	mice	mouse	NNS	NNS	_	13	nsubj	_	_
13	cleared	clear	VBD	VBD	_	9	advcl	_	_
14	the	the	DT	DT	_	15	det	_	_
15	infection	infection	NN	NN	_	13	dobj	_	_
16	similar	similar	JJ	JJ	_	15	amod	_	_
17	to	to	TO	TO	_	16	prep	_	_
18	controls	control	NNS	NNS	_	17	pobj	_	_
19	.	.	.	.	_	5	punct	_	_

1	These	these	DT	DT	_	2	det	_	_
2	data	datum	NNS	NNS	_	3	nsubj	_	_
3	suggest	suggest	VBP	VBP	_	0	ROOT	_	_
4	that	that	IN	IN	_	6	mark	_	_
5	TLR2	tlr2	NN	NN	_	6	nsubj	_	_
6	has	have	VBZ	VBZ	_	3	ccomp	_	_
7	an	a	DT	DT	_	9	det	_	_
8	anti-inflammatory	anti-inflammatory	JJ	JJ	_	9	amod	_	_
9	function	function	NN	NN	_	6	dobj	_	_
10	in	in	IN	IN	_	9	prep	_	_
11	the	the	DT	DT	_	12	det	_	_
12	lung	lung	NN	NN	_	10	pobj	_	_
13	during	during	IN	IN	_	6	prep	_	_
14	Chlamydia	chlamydia	NN	NN	_	15	nn	_	_
15	infection	infection	NN	NN	_	13	pobj	_	_
16	,	,	,	,	_	6	punct	_	_
17	and	and	CC	CC	_	6	cc	_	_
18	that	that	IN	IN	_	26	mark	_	_
19	the	the	DT	DT	_	20	det	_	_
20	role	role	NN	NN	_	26	nsubj	_	_
21	of	of	IN	IN	_	20	prep	_	_
22	TLR2	tlr2	NN	NN	_	21	pobj	_	_
23	in	in	IN	IN	_	20	prep	_	_
24	mucosal	mucosal	JJ	JJ	_	25	amod	_	_
25	inflammation	inflammation	NN	NN	_	23	pobj	_	_
26	varies	vary	VBZ	VBZ	_	6	conj	_	_
27	at	at	IN	IN	_	26	prep	_	_
28	different	different	JJ	JJ	_	30	amod	_	_
29	mucosal	mucosal	JJ	JJ	_	30	amod	_	_
30	surfaces	surface	NNS	NNS	_	27	pobj	_	_
31	.	.	.	.	_	3	punct	_	_
